Trial Profile
Phase Ib/II study of DPV-001 + anti-OX40 in patients with advanced cancer.
Status:
Planning
Phase of Trial:
Phase I/II
Latest Information Update: 18 Aug 2017
Price :
$35
*
At a glance
- Drugs DPV 001 (Primary)
- Indications Cancer
- Focus Adverse reactions; Therapeutic Use
- 18 Aug 2017 New trial record